A former AstraZeneca employee and member of a company due diligence team has agreed to settle insider trading charges brought by the Securities and Exchange Commission (SEC).  

Learn More
Already a member? Sign in to an existing account.

Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government. Email: adrianne.appel@complianceweek.com LinkedIn:...